-
1
Rigosertib inhibits MEK1–ERK pathway and alleviates lipopolysaccharide‐induced sepsis
Published 2021-09-01Subjects: Get full text
Article -
2
Targeting the Microenvironment in MDS: The Final Frontier
Published 2020-07-01Subjects: Get full text
Article -
3
Anti-tumor effects of rigosertib in high-risk neuroblastoma
Published 2021-08-01Subjects: Get full text
Article -
4
Rigosertib-Activated JNK1/2 Eliminate Tumor Cells through p66Shc Activation
Published 2020-05-01Subjects: Get full text
Article -
5
Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na)
Published 2023-04-01Subjects: “…rigosertib…”
Get full text
Article